Tsuyoshi Miyaoka

4PUBLICATIONS
4CO-AUTHORS
PharmacogenomicsMicrobial ecologyAutonomic nervous systemTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 13, 2024
A multicenter, double-blind, randomized, controlled study of patients with treatment-resistant schizophrenia treated with yokukansan for 12 weeks.

Jun Horiguchi, Rei Wake, Kenta Murotani

|Apr 03, 2019
Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia.

Misako Kanayama, Maiko Hayashida, Sadayuki Hashioka

|Jun 05, 2018
Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy.

Misako Kanayama, Tsuyoshi Miyaoka, Tomoko Araki

|May 09, 2015
Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial.

Tsuyoshi Miyaoka, Motohide Furuya, Jun Horiguchi

Pageof 1